| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/27/2008 | EP0981549B9 Use of an inhibitor substance for the improvement of neuronal regeneration |
| 02/27/2008 | EP0896578B1 NOVEL IMIDAZO[1,5-c]QUINAZOLINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS |
| 02/27/2008 | EP0871438B1 Use of alpha-hydroxy acids in the manufacture of a medicament for the treatment of inflammation |
| 02/27/2008 | CN101133144A Method for producing a raw oil from mixtures of micro-organisms and plants, oil produced according to said method and specific uses of the thus produced oil and, optionally, additional refined oil |
| 02/27/2008 | CN101133102A Hyaluronic acid linked with a polymer of an alpha hydroxy acid |
| 02/27/2008 | CN101133075A Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptitde production |
| 02/27/2008 | CN101133074A RNAi modulation of APOB and uses thereof |
| 02/27/2008 | CN101133072A Hydrogels for the controlled release of bioactive materials |
| 02/27/2008 | CN101133070A Novel derivatives of phosphinic amino acids, preparation method thereof and pharmaceutical compositions containing same |
| 02/27/2008 | CN101133065A Purification of rapamycin |
| 02/27/2008 | CN101133064A Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 02/27/2008 | CN101133063A Thienopyridine derivatives and use thereof as hsp90 modulators |
| 02/27/2008 | CN101133061A Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-ce]indol-6-one |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/27/2008 | CN101133057A Triazolophthalazines |
| 02/27/2008 | CN101133055A Compositions and methods for treatment of cancer |
| 02/27/2008 | CN101133054A 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents |
| 02/27/2008 | CN101133053A Substituted pyridine derivatives |
| 02/27/2008 | CN101133052A 1-arylpyrazoles and their use as pesticides |
| 02/27/2008 | CN101133051A Quinoxaline dihydrohalide dihydrates and synthetic methods thereof |
| 02/27/2008 | CN101133050A Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors |
| 02/27/2008 | CN101133049A Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol |
| 02/27/2008 | CN101133047A Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid |
| 02/27/2008 | CN101133045A Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives |
| 02/27/2008 | CN101133043A Method of producing proanthocyanidin oligomer |
| 02/27/2008 | CN101133042A Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 02/27/2008 | CN101133040A Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 02/27/2008 | CN101133039A New enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments |
| 02/27/2008 | CN101133038A HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
| 02/27/2008 | CN101133037A 6-membered heterocyclic compound and use thereof |
| 02/27/2008 | CN101133034A Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
| 02/27/2008 | CN101133028A Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same |
| 02/27/2008 | CN101133027A Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 02/27/2008 | CN101133025A Organic compounds |
| 02/27/2008 | CN101133024A Amide derivatives as inhibitors of histone deacetylase |
| 02/27/2008 | CN101133023A Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof |
| 02/27/2008 | CN101133021A Crystallisation and purification of glycopyrronium bromide |
| 02/27/2008 | CN101133019A Derivatives of aminobutanoic acid inhibiting cpt |
| 02/27/2008 | CN101133018A Glycine transport inhibitors |
| 02/27/2008 | CN101133015A Method of producing chlorogenic acid composition |
| 02/27/2008 | CN101132814A A staining composition for staining an ophthalmic membrane |
| 02/27/2008 | CN101132807A Antiallergic composition |
| 02/27/2008 | CN101132800A Implant for intraocular drug delivery |
| 02/27/2008 | CN101132799A Glucuronide metabolites and epimers thereof of tigecycline |
| 02/27/2008 | CN101132798A Method and composition for treatment of neoplasms |
| 02/27/2008 | CN101132797A Method for treating peripheral vascular diseases |
| 02/27/2008 | CN101132796A Pharmaceutical composition containing phenoxazinium compound as active ingredient |
| 02/27/2008 | CN101132795A Compounds useful in the treatment of HIV |
| 02/27/2008 | CN101132794A CXCR4 antagonists for the treatment of medical disorders |
| 02/27/2008 | CN101132793A The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
| 02/27/2008 | CN101132792A Pharmaceutical composition comprising an indolylmaleimide derivative |
| 02/27/2008 | CN101132791A Biomarkers for identifying efficacy of tegaserod in patients with chronic constipation |
| 02/27/2008 | CN101132790A 维生素混合物 Vitamin mixture |
| 02/27/2008 | CN101132789A Compounds having lipid lowering properties |
| 02/27/2008 | CN101132788A Diosmetin derivative for treating and preventing disease of thrombosis |
| 02/27/2008 | CN101132787A Adjunctive therapy for depression |
| 02/27/2008 | CN101132786A Salts, addition compounds and complex compounds of guanidinoacetic acid |
| 02/27/2008 | CN101132785A N-halogenated amino acids and N, N-dihalogenated amino acids in combination with hypohalous acids |
| 02/27/2008 | CN101132784A Ophthalmic uses of S1P receptor modulators |
| 02/27/2008 | CN101132783A Apogossypolone and the uses thereof |
| 02/27/2008 | CN101132782A Orally tanken medicament preparation of losartan |
| 02/27/2008 | CN101132780A Dosage form and method for sustained release of substituted pyrazine compound |
| 02/27/2008 | CN101132779A Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer |
| 02/27/2008 | CN101132776A Stable tablet formulation of tetrahydrobiopterin |
| 02/27/2008 | CN101132775A Tigecycline compositons and methods of preparation |
| 02/27/2008 | CN101132774A Process for the production of calcium compositions in a continuous fluid bed |
| 02/27/2008 | CN101132770A Nanoparticulate candesartan formulations |
| 02/27/2008 | CN101132766A Tablet containing steroid hormones |
| 02/27/2008 | CN101132763A Topical stabilized prostaglandin E compound dosage forms |
| 02/27/2008 | CN101132762A Production process for NSAID-containing lozenges, their compositions, their medicinal use |
| 02/27/2008 | CN101132698A Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 02/27/2008 | CN101132697A Weight loss composition and method of inducing weight loss |
| 02/27/2008 | CN101132694A Medical device with coating for capturing genetically-altered cells and methods of using same |
| 02/27/2008 | CN101130724A Health care beer having auxiliary inhibit function for tumour and method of producing the same |
| 02/27/2008 | CN101130567A Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 02/27/2008 | CN101130566A Method of preparing 23,24-dihydrocucurbitacin B and use of the same in medicament for treating tumour |
| 02/27/2008 | CN101130561A Method for producing salidroside and injection containing the same |
| 02/27/2008 | CN101130556A Anticancer diaminocyclohexane metallic complex |
| 02/27/2008 | CN101130544A Chemical synthesis method for epinastine |
| 02/27/2008 | CN101130539A Indole-substituteing imidazoline-2-ketones derivant, preparing method and uses of the same |
| 02/27/2008 | CN101130536A Flavanone compound and uses thereof |
| 02/27/2008 | CN101130528A Process for the preparation of baccatin iii derivatives |
| 02/27/2008 | CN101130515A Substituted-1H- indoles compound, method for preparing the same, application and pharmaceutical composition of the same |
| 02/27/2008 | CN101130511A Polyhydroxy opened loop sterol, method for preparing the same and antineoplastic use of the same |
| 02/27/2008 | CN101130491A Oligomer having fatty acid synthase restraining activity and uses thereof |
| 02/27/2008 | CN101130112A Medical device for dispensing medicaments |
| 02/27/2008 | CN101130089A Nucleoside phosphorus acylated coupling chitosan derivant and method of producing the same and application of the same |
| 02/27/2008 | CN101130085A Nano montmorillonite for restraining bacterium and method of preparing the same |
| 02/27/2008 | CN101130084A Compound medicine for depressurization |
| 02/27/2008 | CN101130083A Ophthalmic composition, producing method and use of the same |
| 02/27/2008 | CN101130080A Gelling agent for controlling and releasing 5-HT* acceptor antagon and method of preparing the same |
| 02/27/2008 | CN101130078A Intrathecal administration of rituximab for treatment of central nervous system lymphomas |
| 02/27/2008 | CN101130074A Medicament for treating and/or preventing hepatitis B |
| 02/27/2008 | CN101130069A Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 02/27/2008 | CN101130067A Preparation for replenishing collagen and method of preparing the same |
| 02/27/2008 | CN101130065A Soft capsule of pearl calcium and method of preparing the same |
| 02/27/2008 | CN101130062A Segmented intestine targeted drug feeding preparation of brain protein polypeptide and method of preparing the same |
| 02/27/2008 | CN101130061A Segmented intestine targeted drug feeding preparation of myocardium protein polypeptide and method of producing the same |
| 02/27/2008 | CN101130010A Internally and externally used medicine for treating leukotrichia and alopecia |
| 02/27/2008 | CN101129946A Wet rheumatalgia-relieving plaster for traumatic injury and method of producing the same |